Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
Theranostics in Hematooncology
Andreas K Buck, Sebastian E Serfling, Sabrina Kraus, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapy
Song Xue, Sabrina Kraus, Johanna S Enke, et al.
Cancers
|
June 10, 2022
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography
Aleksander Kosmala, Sebastian E Serfling, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2024
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Wiebke Schloetelburg, Philipp E Hartrampf, Aleksander Kosmala, et al.
Clinical Nuclear Medicine
|
December 11, 2023
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Hematological Malignancies-Myeloablative Effects, Antilymphoma Activity, and Safety Profile
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2026
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [<sup>68</sup>Ga]Ga-LNTH-1363S on Image Quality
Johanna S Enke, Jan Baessler, Gitasha Chand, et al.
Clinical Nuclear Medicine
|
March 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Theranostics
|
January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular risk
Aleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology
|
March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CT
Sebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
Theranostics in Hematooncology
Andreas K Buck, Sebastian E Serfling, Sabrina Kraus, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapy
Song Xue, Sabrina Kraus, Johanna S Enke, et al.
Cancers
|
June 10, 2022
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography
Aleksander Kosmala, Sebastian E Serfling, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2024
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Wiebke Schloetelburg, Philipp E Hartrampf, Aleksander Kosmala, et al.
Clinical Nuclear Medicine
|
December 11, 2023
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Hematological Malignancies-Myeloablative Effects, Antilymphoma Activity, and Safety Profile
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2026
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [<sup>68</sup>Ga]Ga-LNTH-1363S on Image Quality
Johanna S Enke, Jan Baessler, Gitasha Chand, et al.
Clinical Nuclear Medicine
|
March 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Theranostics
|
January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular risk
Aleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology
|
March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CT
Sebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
Page
of 2